What is the ticker symbol for Galmed Pharmaceuticals?

Galmed Pharmaceuticals trades under the ticker GLMD on NASDAQ.

What sector does Galmed Pharmaceuticals operate in?

Galmed Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze GLMD in a portfolio?

PortView shows GLMD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Galmed Pharmaceuticals (GLMD) Stock Analysis

NASDAQHealthcareBiotechnology

$3.91-0.38%

1-year price historyRange $3.75 – $12.88

52-week range$3.91

$3.29$13.20

What Galmed Pharmaceuticals does

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.

Key metrics

Market cap

$4.04M

P/E (TTM)

-0.93

EPS (TTM)

$-4.20

Beta

0.67

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$4.43

200-day avg

$5.42

52-week high

$13.20

52-week low

$3.29

CEO

Allen Baharaff

ETFs linked to GLMD

Broad-market and Healthcare sector ETFs an investor holding Galmed Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how GLMD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GLMD in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Galmed Pharmaceuticals?: Galmed Pharmaceuticals trades under the ticker GLMD on NASDAQ.
Which exchange is GLMD listed on?: GLMD is listed on NASDAQ.
What sector does Galmed Pharmaceuticals operate in?: Galmed Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze GLMD in a portfolio?: PortView shows GLMD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.